APPLICATION
ANDA071511
TYPE
ANDA
ORIGINAL APPROVAL
1987-10-19
LATEST ACTION
2025-08-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
CLORAZEPATE DIPOTASSIUMDiscontinued
CLORAZEPATE DIPOTASSIUM 15MG · CAPSULE · ORAL
Approval history
2025-08-21Labeling · Supplement 5 · standardAP
2025-08-21Labeling · Supplement 3 · standardAP
2016-12-16Labeling · Supplement 1 · standardAP
2016-12-16Labeling · Supplement 2 · standardAP
1987-10-19OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.